S067 Follicular Rescue in Scarring Alopecias: Treating to Halt Disease Progression and Grow Hair
DESCRIPTION
This course will help the dermatologist understand the indications for treating scarring alopecias. The faculty will discuss therapeutic approaches and emerging literature on lichen planopilaris, frontal fibrosing alopecia, and central centrifugal cicatricial alopecia. Dermatoscopic and pathologic cues to viable hair growth in the scarring scalp will be covered. Familiar clinical treatments used in new combinations as well as an approach to healthy hair care practices will be covered. Utilization of new therapies, like PRP and microneedling as well as indications for adding treatments like oral minoxidil for adjunct treatment, will also be discussed.
LEARNING OBJECTIVES
Describe the concept of follicular rescue in scarring forms of hair loss
Demonstrate the signs of treatable scarring alopecias using dermoscopic and pathologic cues
Discuss the therapeutic ladder of treatments to treat scarring alopecias with familiar and new therapies
SCHEDULE
1:00 PM
Introduction
Crystal Aguh, MD, FAAD
1:05 PM
Workup and Diagnosis for FFA/LPP
Kristen Irene Lo Sicco, MD, FAAD
1:30 PM
Workup and Diagnosis for CCCA
Loren Krueger, MD, FAAD
1:55 PM
Metabolic influences and the potential role of GLP-1 agonists in treating cicatricial alopecia
Lindsey Bordone, MD, FAAD
2:20 PM
Medical approach to hair restoration in CCCA
Crystal Aguh, MD, FAAD
2:45 PM
Immunomodulator treatment for scarring alopecia
Maryanne Makredes Senna, MD, FAAD
3:10 PM
Cosmetic and Procedural interventions for scarring alopecia
Ronda S. Farah, MD, FAAD
3:35 PM
Q&A
DIRECTOR
Crystal Aguh, MD, FAAD
SPEAKERS
Lindsey Bordone, MD, FAAD
Ronda S. Farah, MD, FAAD
Loren Krueger, MD, FAAD
Kristen Irene Lo Sicco, MD, FAAD
Maryanne Makredes Senna, MD, FAAD
HANDOUTS
DISCLOSURES
Crystal Aguh, MD, FAAD
CP Skin Health – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Fees); Johnson & Johnson – Other(Residency/Fellowship Program Funding); Pfizer Inc. – Consultant(Fees); Procter & Gamble Company – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Fees); Veradermics – Advisory Board(Fees);
Lindsey Bordone, MD, FAAD
No financial relationships exist with ineligible companies.
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); Intrepid Therapeutics, Inc. – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Sun Pharma Advanced Research Company (SPARC) – Advisory Board(Honoraria); Technoderma Medicines – Investigator(Grants/Research Funding); Veradermics – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Loren Krueger, MD, FAAD
EPG Health – Speaker(Honoraria); Hair Health Summit – Speaker(Honoraria);
Kristen Irene Lo Sicco, MD, FAAD
AQUIS – Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); RegenLab – Investigator(Grants/Research Funding);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);